Suppr超能文献

小切口微透镜取出术后≥5 年的长期疗效和安全性。

Long-term efficacy and safety profiles following small incision lenticule extraction in eyes with ≥ 5-year follow-up.

机构信息

427028Department of Cornea and Refractive Surgery, Instituto Microcirugía Ocular (IMO) Barcelona, Spain.

16719Department of Ophthalmology, Universidad Autónoma de Barcelona (UAB), Barcelona, Spain.

出版信息

Eur J Ophthalmol. 2022 Nov;32(6):3333-3339. doi: 10.1177/11206721221077541. Epub 2022 Feb 1.

Abstract

PURPOSE

To evaluate long-term efficacy, safety, predictability and stability (refractive and keratometric) of myopic and myopic astigmatism correction with Small Incision Lenticule Extraction (SMILE).

METHODS

Single center retrospective review of eyes undergoing SMILE from 2012-2015. Forty-two eyes (23 patients) with ≥ 5-year follow-up. Variables analyzed were preoperative, 3-month, 1-year and last follow-up uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), manifest refraction, spherical equivalent (SE) and mean keratometry. Descriptive statistics were performed and results reported following the Standard for Reporting Astigmatism Outcomes.

RESULTS

Mean follow-up of 5.98 ± 0.90 years. Mean preoperative SE was -5.26 ± 1.22D (range -2.50 to -8.12D). Mean preoperative cylinder was -0.66 ± 0.61D (range 0.00 to -2.25D). Efficacy and safety indices were 0.86 and 0.98, respectively. In total, 81% of operated eyes achieved an UDVA of ≥ 0.09 logMar (20/25 Snellen). At the last follow-up, ≥1 line of CDVA was gained in 14% of eyes. Five percent lost 1 line of CDVA, and no eye loss ≥2 lines of CDVA. Sixty-nine percent of eyes were within ± 0.50D and 86% within ± 1.00D of the attempted SE correction. Ninety-one percent of eyes had ≤0.50D of postoperative astigmatism and 71% were within ± 15° from the intended correction axis. At the final follow-up, a statistically significant myopic regression of 0.19 ± 0.50D was observed (p = 0.01).

CONCLUSIONS

Long-term results demonstrate that SMILE is effective, predictable and safe. SMILE has good stability, low regression compared to LASIK, and no signs of corneal ectasia staging within our standard criteria.

摘要

目的

评估小切口微透镜切除术(SMILE)治疗近视和近视散光的长期疗效、安全性、可预测性和稳定性(屈光和角膜曲率)。

方法

回顾性分析 2012 年至 2015 年期间接受 SMILE 手术的单中心病例。42 只眼(23 例)随访时间≥5 年。分析的变量包括术前、术后 3 个月、1 年和最后一次随访时的未矫正远视力(UDVA)、矫正远视力(CDVA)、主观验光、等效球镜(SE)和平均角膜曲率。采用描述性统计学方法,并按照散光结局报告标准(Standard for Reporting Astigmatism Outcomes)进行结果报告。

结果

平均随访时间为 5.98±0.90 年。平均术前 SE 为-5.26±1.22D(范围-2.50 至-8.12D)。平均术前柱镜为-0.66±0.61D(范围 0.00 至-2.25D)。有效性和安全性指数分别为 0.86 和 0.98。总的来说,81%的手术眼获得了≥0.09 logMar(20/25 Snellen)的 UDVA。在最后一次随访时,14%的眼获得了≥1 行 CDVA 的提高。5%的眼 CDVA 下降 1 行,没有眼 CDVA 下降≥2 行。69%的眼 SE 矫正误差在±0.50D 以内,86%的眼 SE 矫正误差在±1.00D 以内。91%的眼术后散光在≤0.50D 以内,71%的眼在目标矫正轴位的±15°以内。在最后一次随访时,观察到近视回退 0.19±0.50D,具有统计学意义(p=0.01)。

结论

长期结果表明,SMILE 是一种有效、可预测和安全的手术方法。与 LASIK 相比,SMILE 具有良好的稳定性和较低的回退率,并且在我们的标准标准下没有角膜扩张的迹象。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验